Iboga for Sale Online: Why It Is Dangerous

Search for iboga to buy and you will find it. Dedicated vendors, ethnobotanical shops, listings on general-purpose marketplaces, and chemical suppliers listing it for laboratory use. The market is not hidden and it is not difficult to reach.

That availability is often read as reassurance. It is not evidence of anything except that enforcement is thin. This page sets out what is actually known about what gets sold, what the law says, and what happens to people who take it without a clinician looking at them first.

This site publishes no supplier, no vendor link and no affiliate arrangement, and it never will.

The law is not what the shop front suggests

An open listing tells you nothing about your own legal position, which depends entirely on where you are.

Ibogaine is a Schedule I controlled substance under United States federal law, the same category as heroin, meaning no currently accepted medical use, no accepted safety even under medical supervision, and no lawful possession outside DEA-registered research and manufacture. Several other countries treat it as a prescription medicine, which is a different thing again: legal to receive from a physician, not legal to import for yourself. A third group has never scheduled it at all, which is an absence of a decision rather than a finding of safety.

Buying across a border adds a second layer, because importation is regulated separately from possession, and the customs position is often stricter than the domestic one. The legal status by country page sets out where each jurisdiction stands, with the instrument behind it.

What actually arrives

Three quite different products are sold under overlapping names, and the difference matters more than any of the marketing.

None of these arrives with an assay. A gram of one is not a gram of another, and a gram of root bark from one supplier is not a gram from the next.

The consequence is visible in the clinical record. A ten-year case series from the United Kingdom National Poisons Information Service found that the quantities patients reported taking varied from 5g to 34g, with most having taken root bark. Those quantities are not comparable with one another: they cover both tablets and root bark, none of it of stated alkaloid content.

The fatality review makes the same point from the other end, listing the uninformed use of ethnopharmacological forms of ibogaine among the risk factors it identified across nineteen deaths.

What nobody does at your kitchen table

The reason ibogaine is given under monitoring is not ceremony. It is that the way it kills is silent until it is sudden.

Ibogaine blocks the hERG potassium channel that resets the heartbeat, lengthening the QT interval on an electrocardiogram. A long QT produces no sensation whatsoever. It is detectable only on an ECG, and its dangerous consequence, an arrhythmia called torsade de pointes, can arrive hours after someone believes the experience is over.

In that same United Kingdom series, six of seven patients showed features of cardiotoxicity, including cardiac arrest, torsade de pointes, QT prolongation and bradycardia. The reported sources of their material were an online purchase, a dealer, and in two cases a shaman.

None of the following is possible alone at home: a baseline ECG with a calculated QTc, a blood panel showing whether potassium and magnesium are low enough to lengthen the interval further, continuous cardiac monitoring through the night, or a defibrillator and someone trained to use it in the room. The mechanism and what screening is meant to catch are set out on ibogaine and the heart; what the drug does that you can actually feel is on ibogaine side effects.

The interactions that catch people out

A great deal of what makes solitary use dangerous is not the iboga. It is what else is in the body.

Methadone and several other opioids lengthen the QT interval themselves, and combining two QT-prolonging drugs is additive. People arriving at ibogaine frequently arrive from exactly these medications. Stimulants raise the cardiac demand at the wrong moment. Withdrawal from alcohol or benzodiazepines carries its own seizure risk, which the fatality review identified separately, and attempting to time an ibogaine dose around that withdrawal without supervision stacks two emergencies.

Low potassium deserves its own mention because it is so ordinary. Vomiting is a common effect of ibogaine, and it depletes potassium. Low potassium lengthens the QT interval. At home nobody measures it, and in the published arrhythmia cases it was low wherever it was checked.

What we cannot tell you, and will not

We cannot tell you a safe amount. The largest randomised, double-blind trial completed in January 2024 without publishing results, and nothing that has reported establishes one. This site does not publish dosing protocols, and a page that prints a number for material of unknown strength would be worse than useless.

On adulteration, there is now one documented case and it is a death.

A thirty-year-old woman died after ingesting a powder labelled as Tabernanthe iboga that she had bought online. Analysis of the powder found no ibogaine at all. What it contained were ajmaline, yohimbine and reserpine, alkaloids of Rauvolfia, an entirely different genus. All three were quantified in her blood and at roughly ten times those concentrations in bile. The forensic conclusion attributed death to ingestion of a substantial quantity of crushed Rauvolfia root alongside concomitant drug withdrawal.

One case does not establish how often this happens, and we do not know. What it establishes is that the failure mode is real, that it is not a matter of getting a stronger or weaker batch, and that a person following every precaution about quantity would have been following them for the wrong plant.

Strength has been tested more systematically, and the result is stark. A 2020 analysis of sixteen commercial products bought from five vendors across nine countries found ibogaine content ranging from 0.6 to 11.2 per cent in material sold as root bark, and from 61.5 to 73.4 per cent in material sold as ibogaine hydrochloride. One sample contained no iboga alkaloids at all.

So a product labelled as the purified compound was, in that sample, between a quarter and two-fifths short of what its name implies. That is a measured finding rather than an inference, and it is the strongest available answer to anyone who believes a purified label removes the uncertainty. So two separate things are documented. The alkaloid content of plant material varies enough on its own to make any amount unknowable. And on at least one occasion the material was not the plant at all.

If you are going to do this regardless of everything above, the harm-reduction measures with actual evidence behind them are narrow but real: have someone else present who is not taking anything and who will call emergency services without hesitating; know that the dangerous window extends many hours past the experience; be honest with clinicians about what was taken, because they cannot manage a rhythm they do not know to look for, and the interventions tried in published cases have often failed to resolve it; and understand that no amount of preparation at home substitutes for an ECG.

Where people take it instead

Ordering a package removes the one thing every other route retains, which is another person who is answerable for what happens. Three settings exist. We name none of them individually, and we take nothing from anyone who does.

A specialised clinic. The medical route exists in several jurisdictions, and its value is entirely in what it actually does rather than in what it calls itself. The criteria worth asking about are the ones on this site’s screening list: a baseline ECG read by someone qualified, potassium and magnesium corrected before dosing, a full medication history taken seriously, cardiac monitoring that continues through the night rather than ending when the acute phase does, and resuscitation equipment in the room with staff able to use it. A provider who cannot answer those questions plainly has answered them. Standards vary enormously between places that use the same words about themselves, which is why ibogaine and the heart lists what the screening is for rather than who provides it.

A village, with Bwiti practitioners. Iboga is not a molecule that happened to be found in Gabon. It belongs to an initiatory tradition with its own rules about who may take it, when, in what quantity, under whose supervision and after what preparation, and those rules were worked out over generations by people who were accountable to the person in front of them. A practitioner trained within that tradition is doing something categorically different from a parcel arriving in the post. It is also, for many, the only context in which the plant makes sense at all.

Two things follow, and we state both. The published fatality series deliberately counted only deaths outside West Central Africa, so the record for traditional use is not in that literature. We do not read that absence as evidence of safety, and we will not claim it is. What we can say is that a ceremonial setting does not include an electrocardiogram, and the cardiac risk described on this site does not recognise cultural context. Anyone considering that route should have their heart looked at first, somewhere that can do it.

A registered trial. A small number exist. Their current recruitment status is on ClinicalTrials.gov, worth checking directly rather than trusting a date on this page.

What all three share, and what a package does not, is somebody present who knows what was taken and is equipped to act on it.